Drug:
Reaction: SEIZURE
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25492032 |
US |
2 | |
General physical health deterioration, Death, Seizure, Accidental overdose, Neck pain, Nervousness, Therapeutic response shortened, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, PYRIDOSTIGMINE BROMIDE, |
||||
2 | 25492764 |
US |
75 | 2 |
Seizure, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, DIAZEPAM, |
||||
3 | 25492782 |
US |
52 | 2 |
Seizure, Arthralgia, Stress, Insomnia, |
||||
UPADACITINIB, |
||||
4 | 25492840 |
FR |
||
Death, Seizure, |
||||
PREGABALIN, |
||||
5 | 25493220 |
US |
2 | |
Seizure, Dizziness, Fatigue, Somnolence, Injection related reaction, Blood iron decreased, Temperature intolerance, |
||||
OFATUMUMAB, |
||||
6 | 25493606 |
US |
1 | |
Seizure, Cardiac disorder, |
||||
CETUXIMAB, |
||||
7 | 25493610 |
US |
27 | 2 |
Seizure, Loss of consciousness, Device breakage, Incorrect product administration duration, Product use in unapproved indication, |
||||
ETONOGESTREL, ETONOGESTREL, |
||||
8 | 25493755 |
US |
33 | 2 |
Seizure, |
||||
OMAVELOXOLONE, BUPROPION HYDROCHLORIDE, |
||||
9 | 25493985 |
US |
2 | |
Seizure, Product dose omission issue, |
||||
TROFINETIDE, TROFINETIDE, |
||||
10 | 25494136 |
CA |
14 | 1 |
Coma scale abnormal, Encephalitis, Seizure, Hospitalisation, |
||||
NIVOLUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DACARBAZINE, DEXRAZOXANE FOR INJECTION, DEXRAZOXANE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
11 | 25494444 |
CN |
56 | 1 |
Anaphylactic shock, Syncope, Loss of consciousness, Seizure, Vision blurred, Flushing, Blood pressure decreased, Conjunctival oedema, |
||||
IOPROMIDE, |
||||
12 | 25494613 |
DE |
26 | 2 |
Tardive dyskinesia, Altered state of consciousness, Seizure, Taste disorder, Restlessness, Urinary incontinence, Nausea, |
||||
LACOSAMIDE, BRIVARACETAM, |
||||
13 | 25494637 |
US |
2 | |
Cerebrovascular accident, Seizure, Gastric operation, Central nervous system lesion, Ulcer, Arthralgia, Illness, Impaired work ability, Skin disorder, |
||||
BELIMUMAB, |
||||
14 | 25494757 |
US |
70 | 2 |
Seizure, |
||||
CARBAMAZEPINE, |
||||
15 | 25494991 |
TW |
50 | 2 |
Posterior reversible encephalopathy syndrome, Serotonin syndrome, Loss of consciousness, Seizure, Overdose, Gaze palsy, Urinary incontinence, |
||||
MIRTAZAPINE, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, ZOLPIDEM TARTRATE, |
||||
16 | 25495055 |
US |
||
Respiratory arrest, Skin discolouration, Generalised tonic-clonic seizure, Seizure, Seizure, Somnolence, Visual impairment, Tremor, |
||||
TOPIRAMATE, OXCARBAZEPINE, |
||||
17 | 25495088 |
US |
1 | |
Seizure, Adverse drug reaction, Therapeutic response unexpected, Product taste abnormal, |
||||
EXTENDED PHENYTOIN SODIUM, EXTENDED PHENYTOIN SODIUM, |
||||
18 | 25495163 |
US |
||
Seizure, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
19 | 25495241 |
CA |
22 | 2 |
Loss of consciousness, Seizure, |
||||
RISANKIZUMAB-RZAA, |
||||
20 | 25495277 |
US |
3 | 1 |
Seizure, |
||||
VIGABATRIN, |
||||
21 | 25495343 |
AU |
1 | |
Blindness cortical, Intellectual disability, Seizure, Fall, Injury, Mobility decreased, Mood swings, |
||||
FLUOXETINE HYDROCHLORIDE, CARBAMAZEPINE, TOPIRAMATE, TOPIRAMATE SPINKLE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CLOBAZAM, PHENOBARBITAL, RUFINAMIDE, ZONISAMIDE, ZONISAMIDE, CANNABIDIOL, |
||||
22 | 25496005 |
US |
46 | 2 |
Seizure, |
||||
RIMEGEPANT SULFATE, EPTINEZUMAB-JJMR, DIHYDROERGOTAMINE MESYLATE, |
||||
23 | 25496208 |
US |
||
Seizure, Malignant neoplasm progression, |
||||
VORASIDENIB, |
||||
24 | 25496483 |
US |
60 | 2 |
Seizure, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
25 | 25499790 |
34 | 2 | |
Seizure, Product communication issue, |
||||
FLUCONAZOLE, |
||||
26 | 25491208 |
US |
6 | 1 |
Rhinovirus infection, Seizure, |
||||
VIGABATRIN, |
||||
27 | 25491210 |
US |
1 | |
Seizure, |
||||
VIGABATRIN, |
||||
28 | 25491214 |
US |
2 | |
Seizure, Product dose omission issue, |
||||
VIGABATRIN, |
||||
29 | 25491215 |
US |
1 | |
Seizure, |
||||
VIGABATRIN, |
||||
30 | 25491224 |
US |
2 | |
Infantile spasms, Seizure, Infantile spitting up, Rash, Insomnia, Incorrect dose administered, |
||||
VIGABATRIN, VIGABATRIN, |
||||
31 | 25491231 |
US |
7 | |
Seizure, |
||||
VIGABATRIN, |
||||
32 | 25491235 |
US |
0 | |
Seizure, |
||||
VIGABATRIN, |
||||
33 | 25491236 |
US |
||
Seizure, |
||||
VIGABATRIN, |
||||
34 | 25491238 |
US |
||
Seizure, Infantile spitting up, Weight increased, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, |
||||
35 | 25491243 |
US |
0 | |
Seizure, |
||||
VIGABATRIN, VIGABATRIN, |
||||
36 | 25491410 |
RO |
79 | 2 |
Seizure, Bone pain, Eastern Cooperative Oncology Group performance status worsened, |
||||
PEMBROLIZUMAB, |
||||
37 | 25491449 |
US |
28 | 2 |
Acute hepatic failure, Seizure, Migraine, Renal disorder, |
||||
NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, LEVOTHYROXINE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
38 | 25491473 |
DE |
85 | 2 |
Seizure, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
39 | 25491503 |
US |
48 | 1 |
Seizure, Dizziness, Fatigue, Stress, Mood altered, Neck pain, Back pain, Pain in extremity, |
||||
ADALIMUMAB, |
||||
40 | 25491578 |
US |
74 | 2 |
Seizure, Fall, Swelling face, Fat tissue increased, Eye contusion, Stress, |
||||
ADALIMUMAB, |
||||
41 | 25490129 |
US |
||
Seizure, |
||||
BLINATUMOMAB, |
||||
42 | 25490286 |
US |
1 | 2 |
Seizure, Viral infection, |
||||
VIGABATRIN, |
||||
43 | 25490289 |
US |
1 | |
Seizure, Urinary tract infection, |
||||
VIGABATRIN, |
||||
44 | 25490424 |
US |
||
Surgery, Seizure, Product dose omission in error, |
||||
IVOSIDENIB, |
||||
45 | 25484564 |
|||
Seizure, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
46 | 25484653 |
|||
Seizure, |
||||
LEVETIRACETAM, |
||||
47 | 25486795 |
CA |
30 | 1 |
Product substitution issue, Headache, Seizure, |
||||
OXCARBAZEPINE, |
||||
48 | 25486924 |
CA |
12 | 1 |
Insulin-like growth factor increased, Pyrexia, Tremor, Stress, Hepatotoxicity, Nausea, Needle issue, Eye movement disorder, Agitation, Product use issue, Diarrhoea, Fall, Treatment failure, Brain injury, Hepatic enzyme increased, Helicobacter infection, Strabismus, Infrequent bowel movements, Vomiting, Chest pain, Gastric hypomotility, Injection site pain, Contusion, Seizure, Shunt occlusion, Swelling, Obsessive-compulsive disorder, Breath odour, Blood growth hormone increased, Gait disturbance, Cough, Viral diarrhoea, Neoplasm progression, Injection site haemorrhage, Eructation, Foot deformity, Influenza, Shunt malfunction, Device malfunction, Constipation, Growth hormone-producing pituitary tumour, Abdominal pain, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, MORPHINE SULFATE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, HYDROCORTISONE, HYDROCORTISONE, MELATONIN, PROPRANOLOL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, ATOMOXETINE HYDROCHLORIDE, CARBAMAZEPINE, ATOMOXETINE, ATOMOXETINE, TESTOSTERONE, TESTOSTERONE,, PRIMIDONE, PRIMIDONE, PRIMIDONE, PEGVISOMANT, RISPERIDONE, HYDROCORTISONE ACETATE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
49 | 25486982 |
FR |
4 | |
Seizure, |
||||
FENFLURAMINE, |
||||
50 | 25487025 |
US |
2 | |
Seizure, Brain fog, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, |
||||
51 | 25487711 |
US |
24 | 2 |
Seizure, Generalised tonic-clonic seizure, Myoclonic epilepsy, Myoclonus, Product dose omission issue, |
||||
FENFLURAMINE, FENFLURAMINE, CLONAZEPAM, MIDAZOLAM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, CLOBAZAM, CLOBAZAM, VALPROIC ACID, |
||||
52 | 25487768 |
IT |
11 | 1 |
Posterior reversible encephalopathy syndrome, Seizure, Hypertension, Product use in unapproved indication, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, FLUDARABINE PHOSPHATE, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, THIOTEPA, VALPROATE SODIUM, VALPROIC ACID, |
||||
53 | 25488096 |
GB |
76 | 2 |
Seizure, |
||||
LINEZOLID, |
||||
54 | 25488179 |
IT |
18 | 1 |
Seizure, Drug ineffective, |
||||
FENFLURAMINE, |
||||
55 | 25488217 |
US |
58 | 2 |
Seizure, Brain fog, |
||||
TERIFLUNOMIDE, |
||||
56 | 25488315 |
IT |
1 | |
Seizure, Haemoglobin abnormal, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, |
||||
57 | 25488386 |
CN |
74 | 1 |
Off label use, Seizure, Dyspnoea, Pyrexia, Chills, |
||||
SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, |
||||
58 | 25488474 |
US |
||
Seizure, |
||||
BLINATUMOMAB, |
||||
59 | 25488603 |
US |
||
Seizure, |
||||
BLINATUMOMAB, |
||||
60 | 25489090 |
US |
47 | 2 |
Seizure, Swollen tongue, Hypoaesthesia oral, Haemoptysis, |
||||
61 | 25489544 |
US |
||
Seizure, |
||||
BLINATUMOMAB, |
||||
62 | 25489949 |
US |
11 | 2 |
Product preparation error, Seizure, |
||||
LEVACETYLLEUCINE, CANNABIDIOL, CLOBAZAM, LACOSAMIDE, MAGNESIUM, ZINC SULFATE, ZINC SULFATE INJECTION,, ZINC SULFATE INJECTION, MELATONIN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
63 | 25490610 |
JP |
||
Opisthotonus, Neuroleptic malignant syndrome, Tardive dyskinesia, Seizure, Dyspnoea, |
||||
LURASIDONE HYDROCHLORIDE, |
||||
64 | 25493926 |
69 | 1 | |
Seizure, |
||||
ABIRATERONE ACETATE, ABIRATERONE, METOPROLOL TARTRATE, METOPROLOL, |
||||
65 | 25481591 |
US |
4 | 1 |
Coma, Seizure, Cardiac disorder, Productive cough, Breast enlargement, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, |
||||
66 | 25481921 |
US |
||
Seizure, |
||||
TROFINETIDE, |
||||
67 | 25481960 |
US |
||
Seizure, Mood altered, Diarrhoea, Vomiting, Drug ineffective, |
||||
TROFINETIDE, |
||||
68 | 25482232 |
US |
2 | |
Seizure, Urinary tract infection, |
||||
TROFINETIDE, |
||||
69 | 25482450 |
US |
7 | 2 |
Seizure, Pyrexia, Pharyngitis streptococcal, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
70 | 25483160 |
ES |
||
Epilepsy, Seizure, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
71 | 25483690 |
US |
20 | 1 |
Pneumonia, Seizure, Oral surgery, Tracheostomy, Hypernatraemia, Wrong technique in product usage process, Off label use, |
||||
FENFLURAMINE, LEVETIRACETAM, LEVETIRACETAM, CLOBAZAM, CANNABIDIOL, GANAXOLONE, DIAZEPAM, SERTRALINE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ENOXAPARIN SODIUM, POLYETHYLENE GLYCOL 3350, FERROUS SULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, EPINEPHRINE, |
||||
72 | 25483759 |
CA |
1 | |
Acute kidney injury, Tumour lysis syndrome, Myalgia, Blood bilirubin increased, Vomiting, Haematuria, Seizure, Infection, Cerebral ischaemia, Cystitis noninfective, Alanine aminotransferase increased, Aspartate aminotransferase increased, Pulmonary embolism, Thrombosis, Anaemia, Drug interaction, Febrile neutropenia, |
||||
VINCRISTINE SULFATE, RITONAVIR, RITONAVIR 100 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, NEVIRAPINE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FOSAMPRENAVIR CALCIUM, ATAZANAVIR SULFATE, ATAZANAVIR, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, EFAVIRENZ, RALTEGRAVIR, ZIDOVUDINE, PREDNISONE, LOPINAVIR AND RITONAVIR, |
||||
73 | 25484578 |
70 | 2 | |
Seizure, |
||||
PIMAVANSERIN TARTRATE, |
||||
74 | 25485157 |
US |
37 | 2 |
Seizure, Tongue injury, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
75 | 25485446 |
US |
||
Craniotomy, Cardiac arrest, Loss of consciousness, Product dose omission issue, Seizure, Feeling abnormal, Product dose omission issue, |
||||
ZONISAMIDE, |
||||
76 | 25485448 |
US |
||
Choking, Seizure, Product use issue, |
||||
77 | 25485469 |
US |
||
Neoplasm malignant, Seizure, Product dose omission issue, Burning sensation, |
||||
LACOSAMIDE, PRIMIDONE, |
||||
78 | 25485523 |
US |
||
Seizure, Somnolence, |
||||
VIGABATRIN, VIGABATRIN, |
||||
79 | 25476085 |
CN |
33 | 1 |
Leukopenia, Seizure, Disease progression, Brain neoplasm, Adenocarcinoma, Lymphangiosis carcinomatosa, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, |
||||
80 | 25476544 |
BR |
1 | |
Bacterial infection, Seizure, Foetal exposure during pregnancy, |
||||
INFLIXIMAB, |
||||
81 | 25476668 |
US |
||
Seizure, |
||||
METOLAZONE, |
||||
82 | 25476764 |
US |
47 | 2 |
Seizure, Unresponsive to stimuli, Arteriovenous malformation, Urinary tract infection, Lyme disease, Speech disorder, Visual impairment, Infection, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, |
||||
83 | 25477363 |
US |
1 | |
Seizure, Fall, Gout, Nausea, Fatigue, Blood creatine phosphokinase increased, Diarrhoea, Constipation, Headache, |
||||
84 | 25477426 |
US |
2 | |
Seizure, |
||||
RISANKIZUMAB-RZAA, |
||||
85 | 25477774 |
GB |
42 | 2 |
Hemianopia homonymous, Photopsia, Generalised tonic-clonic seizure, Tongue biting, Postictal state, Mass, Cerebral fungal infection, Hemiparesis, Facial paresis, Vasogenic cerebral oedema, Partial seizures, Headache, Fatigue, Muscular weakness, Abscess, Movement disorder, Pneumonia fungal, Fungal skin infection, Rhinitis, Seizure, Fluorosis, Drug ineffective, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VORICONAZOLE, VORICONAZOLE, VORICONAZOLE, VORICONAZOLE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CANAGLIFLOZIN, CANAGLIFLOZIN, CANAGLIFLOZIN, CANAGLIFLOZIN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, FLUCYTOSINE, FLUCYTOSINE, FLUCYTOSINE, FLUCYTOSINE, |
||||
86 | 25477787 |
US |
45 | 1 |
Seizure, Therapy interrupted, Product availability issue, Product use in unapproved indication, |
||||
BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, |
||||
87 | 25477880 |
DE |
14 | 2 |
Seizure, Pyrexia, |
||||
88 | 25478094 |
US |
43 | 1 |
Seizure, |
||||
DIROXIMEL FUMARATE, |
||||
89 | 25478297 |
US |
57 | 2 |
Tachycardia, Contraindicated product administered, Seizure, |
||||
ALBUTEROL SULFATE, ALBUTEROL, SERTRALINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN AND CODEINE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BUSPIRONE HYDROCHLORIDE, DESONIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LEVETIRACETAM, METOPROLOL TARTRATE, METOPROLOL, EPINEPHRINE, ADRENALINUM, IPRATROPIUM BROMIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
90 | 25478380 |
US |
38 | 1 |
Seizure, Treatment noncompliance, |
||||
BRIVARACETAM, |
||||
91 | 25478668 |
US |
2 | |
Seizure, Diarrhoea, |
||||
FENFLURAMINE, |
||||
92 | 25478713 |
GB |
8 | 1 |
Seizure, Brain oedema, Brain injury, Heart rate increased, Pain, Chills, Dyskinesia, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
93 | 25479263 |
71 | 1 | |
Vomiting, Seizure, Oxygen saturation decreased, |
||||
94 | 25479802 |
NL |
||
Hyponatraemia, Acute respiratory failure, Seizure, Overdose, |
||||
DESMOPRESSIN ACETATE, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, AMLODIPINE, AMITRIPTYLINE HYDROCHLORIDE, PANTOPRAZOLE, |
||||
95 | 25479861 |
US |
2 | |
Seizure, Parkinson^s disease, Thinking abnormal, Vomiting, |
||||
INSULIN ASPART, |
||||
96 | 25480145 |
IL |
85 | 1 |
Seizure, Amnesia, Fatigue, Condition aggravated, Drug ineffective, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, PEMBROLIZUMAB, ENZALUTAMIDE, |
||||
97 | 25480175 |
US |
37 | 2 |
Seizure, Memory impairment, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
98 | 25480522 |
GB |
1 | |
Seizure, Malaise, |
||||
DONANEMAB-AZBT, |
||||
99 | 25481088 |
EG |
37 | 1 |
Seizure, Cerebral venous sinus thrombosis, Headache, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, KETOROLAC TROMETHAMINE, |
||||
100 | 25470357 |
US |
2 | 1 |
Seizure, Prescribed overdose, Drug ineffective, |
||||
CANNABIDIOL, CANNABIDIOL, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29